Show simple item record

dc.contributor.authorTan, Wei Shen
dc.contributor.authorArianayagam, Ranjan
dc.contributor.authorKhetrapal, Pramit
dc.contributor.authorRowe, Edward
dc.contributor.authorKearley, Samantha
dc.contributor.authorMahrous, Ahmed
dc.contributor.authorPal, Raj
dc.contributor.authorFowler, William
dc.contributor.authorHeer, Rakesh
dc.contributor.authorElajnaf, Mohamed
dc.contributor.authorDouglas-Moore, Jayne
dc.contributor.authorGriffiths, TR Leyshon
dc.contributor.authorVoss, James
dc.contributor.authorWilby, Daniel
dc.contributor.authorAl Kadhi, Omar
dc.contributor.authorNoel, Jonathan
dc.contributor.authorVasdev, Nikhil
dc.contributor.authorMcKay, Alastair
dc.contributor.authorAhmad, Imran
dc.contributor.authorAbu-Nayla, Islam
dc.contributor.authorLamb, Benjamin
dc.contributor.authorHill, George T
dc.contributor.authorNarahari, Krishna
dc.contributor.authorKynaston, Howard
dc.contributor.authorYousuf, Arzu
dc.contributor.authorKusuma, Venkata RM
dc.contributor.authorCresswell, Joanne
dc.contributor.authorCooke, Pete
dc.contributor.authorChakravarti, Aniruddha
dc.contributor.authorBarod, Ravi
dc.contributor.authorBex, Axel
dc.contributor.authorKelly, John D
dc.date.accessioned2021-03-25T00:12:35Z
dc.date.available2021-03-25T00:12:35Z
dc.date.issued2021-03
dc.identifier.citationTan , W S , Arianayagam , R , Khetrapal , P , Rowe , E , Kearley , S , Mahrous , A , Pal , R , Fowler , W , Heer , R , Elajnaf , M , Douglas-Moore , J , Griffiths , TR L , Voss , J , Wilby , D , Al Kadhi , O , Noel , J , Vasdev , N , McKay , A , Ahmad , I , Abu-Nayla , I , Lamb , B , Hill , G T , Narahari , K , Kynaston , H , Yousuf , A , Kusuma , V RM , Cresswell , J , Cooke , P , Chakravarti , A , Barod , R , Bex , A & Kelly , J D 2021 , ' Major urological cancer surgery for patients is safe and surgical training should be encouraged during the COVID-19 pandemic : A multi-centre analysis of 30-day outcomes ' , European Urology Open Science , vol. 25 , pp. 39-43 . https://doi.org/10.1016/j.euros.2021.01.005
dc.identifier.issn2666-1683
dc.identifier.otherPURE: 24344296
dc.identifier.otherPURE UUID: e306d2f0-c474-4e7c-81a0-6f2538247cdf
dc.identifier.otherPubMed: 33458711
dc.identifier.otherScopus: 85100443380
dc.identifier.urihttp://hdl.handle.net/2299/24155
dc.descriptionFunding Information: Funding/Support and role of the sponsor: Wei Shen Tan is funded by the Urology Foundation . Publisher Copyright: © 2021 The Author(s) Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
dc.description.abstractCOVID-19 has resulted in the deferral of major surgery for genitourinary (GU) cancers with the exception of cancers with a high risk of progression. We report outcomes for major GU cancer operations, namely radical prostatectomy (RP), radical cystectomy (RC), radical nephrectomy (RN), partial nephrectomy (PN), and nephroureterectomy performed at 13 major GU cancer centres across the UK between March 1 and May 5, 2020. A total of 598 such operations were performed. Four patients (0.7%) developed COVID-19 postoperatively. There was no COVID-19–related mortality at 30 d. A minimally invasive approach was used in 499 cases (83.4%). A total of 228 cases (38.1%) were described as training procedures. Training case status was not associated with a higher American Society of Anesthesiologists (ASA) score (p = 0.194) or hospital length of stay (LOS; p > 0.05 for all operation types). The risk of contracting COVID-19 was not associated with longer hospital LOS (p = 0.146), training case status (p = 0.588), higher ASA score (p = 0.295), or type of hospital site (p = 0.303). Our results suggest that major surgery for urological cancers remains safe and training should be encouraged during the ongoing COVID-19 pandemic provided appropriate countermeasures are taken. These real-life data are important for policy-makers and clinicians when counselling patients during the current pandemic. Patient summary: We collected outcome data for major operations for prostate, bladder, and kidney cancers during the COVID-19 pandemic. These surgeries remain safe and training should be encouraged during the ongoing pandemic provided appropriate countermeasures are taken. Our real-life results are important for policy-makers and clinicians when counselling patients during the COVID-19 pandemic.en
dc.format.extent5
dc.language.isoeng
dc.relation.ispartofEuropean Urology Open Science
dc.subjectCOVID-19
dc.subjectCystectomy
dc.subjectMortality
dc.subjectNephrectomy
dc.subjectOutcomes
dc.subjectProstatectomy
dc.subjectUrology
dc.titleMajor urological cancer surgery for patients is safe and surgical training should be encouraged during the COVID-19 pandemic : A multi-centre analysis of 30-day outcomesen
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionBasic and Clinical Science Unit
dc.contributor.institutionExtracellular Vesicle Research Unit
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionDepartment of Clinical, Pharmaceutical and Biological Science
dc.description.statusPeer reviewed
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85100443380&partnerID=8YFLogxK
rioxxterms.versionVoR
rioxxterms.versionofrecordhttps://doi.org/10.1016/j.euros.2021.01.005
rioxxterms.typeOther
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record